The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
December 2nd 2024
Ustekinumab-kfce is planned for launch in February 2025 according to a previous settlement and license agreement with Janssen.
November 27th 2024
November 26th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Management of Lupus in 2010: How Close are the Biologics?
November 1st 2010The classic therapies for patients with systemic lupus erythematosus (SLE) often have significant toxicity. Corticosteroids provide a critical intervention when the disease is organ- or life-threatening, but the potential adverse effects are numerous.
Meeting the challenge of chronic shoulder pain: Treatment
October 30th 2010Chronic shoulder pain has a variety of causes, and treatment is multifaceted. Physical therapy typically is the first step; therapy for osteoarthritis (OA) should strike a balance between regaining and maintaining motion and strength and avoiding aggravation of the patient’s condition.
Physicians misguided about misuse of opioids?
October 29th 2010A majority of physicians think that only a small number of their patients misuse or abuse opioid analgesics obtained from a prescription and just more than half think that most cases of opioid abuse do not involve tampering with the medication’s delivery system, according to a national survey sponsored by the American Pain Foundation (APF).
Physician consensus and case analysis help establish new RA criteria
October 28th 2010American College of Rheumatology and European League Against Rheumatism investigators who developed new classification criteria for rheumatoid arthritis (RA) used a consensus-based, decision analysis approach during phase 2 that included evaluation of case scenarios to identify predictive factors for persistent inflammatory or erosive arthritis.